Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Drug Safety|April 1, 1994
Risk-benefit assessment of drug treatment to prevent coronary heart disease. Estimating the benefits of risk factor modificationS A Grover, L CoupalAmerican Journal of Epidemiology|February 1, 1995
Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standardL Joseph, T W Gyorkos, L CoupalJAMA|September 13, 1995
Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?S A Grover, L Coupal, X P HuArchives of Internal Medicine|March 28, 1994
Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohortS A Grover, C S Palmer, L CoupalCMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 15, 1991
Screening for hypercholesterolemia among Canadians: how much will it cost?S A Grover, L Coupal, R Fahkry, et al.Journal of Cardiopulmonary Rehabilitation|June 22, 2000
The cost-effectiveness of exercise training for the primary and secondary prevention of cardiovascular diseaseI Lowensteyn, L Coupal, H Zowall, et al.Circulation|August 16, 2000
Cost-effectiveness of treating hyperlipidemia in the presence of diabetes : who should be treated?S A Grover, L Coupal, H Zowall, et al.Archives of Internal Medicine|March 25, 1999
Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: forecasting the incremental benefits of preventing coronary and cerebrovascular eventsS A Grover, L Coupal, S Paquet, et al.Journal of General Internal Medicine|September 1, 1991
Seizure vs. syncope: measuring serum creatine kinase in the emergency departmentM D Libman, L Potvin, L Coupal, et al.Archives of Internal Medicine|April 1, 1998
Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary preventionS A Grover, S Paquet, C Levinton, et al.Pageof 3